We are live on
!
Find out more
PHS
PFM Health Sciences Portfolio holdings
AUM
$1.1B
1-Year Est. Return
57.92%
This Fund
S&P 500
This Quarter
Est. Return
+6.71%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$4.92B
AUM Growth
+$705M
(+17%)
Cap. Flow
+$556M
Cap. Flow
% of AUM
11.29%
Top 10 Holdings %
Top 10 Hldgs %
30.88%
Holding
109
New
27
Increased
28
Reduced
31
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$201M |
| 2 |
Viatris
VTRS
|
+$197M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
+$167M |
| 4 |
Elevance Health
ELV
|
+$92.3M |
| 5 |
Tenet Healthcare
THC
|
+$70.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
+$84.6M |
| 2 |
ServiceNow
NOW
|
+$80.6M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$73.7M |
| 4 |
Cigna
CI
|
+$60.3M |
| 5 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
+$48.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 59.98% |
| 2 | Technology | 11.1% |
| 3 | Communication Services | 4.51% |
| 4 | Financials | 2.87% |
| 5 | Consumer Discretionary | 2.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NCNA
76
NuCana
NCNA
$5.49M
| $8.46M | 0.17% |
+89
| New | +$8.45M |
|
77
PagSeguro Digital
PAGS
$2.69B
| $7.53M | 0.15% |
+196,418
| New | +$6.31M |
|
78
AnaptysBio
ANAB
$1.58B
| $7.32M | 0.15% |
70,354
-355,542
| -83% | -$40.1M |
|
|
OPTN
79
DELISTED
OptiNose
OPTN
| $6.69M | 0.14% |
22,286
+758
| +4% | +$210K |
|
|
NXGN
80
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $6.05M | 0.12% |
+443,210
| New | +$5.84M |
|
|
IVTY
81
DELISTED
Invuity, Inc
IVTY
| $5.24M | 0.11% |
1,360,334
+267,355
| +24% | +$1.22M |
|
|
CMTA
82
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
| $4.89M | 0.1% |
322,732
+10,977
| +4% | +$179K |
|
|
GBT
83
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $3.23M | 0.07% |
+66,967
| New | +$3.74M |
|
84
Zscaler
ZS
$24.5B
| $1.37M | 0.03% |
+48,726
| New | +$1.43M |
|
|
85
ServiceNow
NOW
$115B
| $789K | 0.02% |
23,835
-2,612,870
| -99% | -$80.6M |
|
86
Inogen
INGN
$175M
| $204K | ﹤0.01% |
1,657
-90,172
| -98% | -$11M |
|
87
American Tower
AMT
$80.8B
| – | – |
-123,478
| Closed | -$17.6M |
|
|
88
Cigna
CI
$73.7B
| – | – |
-297,035
| Closed | -$60.3M |
|
89
DXC Technology
DXC
$1.82B
| – | – |
-539,926
| Closed | -$44.3M |
|
90
CALL
Humana
HUM
$43.7B
| – | – |
-82,200
| Closed | -$20.4M |
|
91
Meta Platforms (Facebook)
META
$1.42T
| – | – |
-3,670
| Closed | -$648K |
|
92
PUT
Invesco QQQ Trust
QQQ
$453B
| – | – |
-701,100
| Closed | -$109M |
|
|
93
Regeneron Pharmaceuticals
REGN
$78.5B
| – | – |
-196,112
| Closed | -$73.7M |
|
94
Universal Health Services
UHS
$10.2B
| – | – |
-413,671
| Closed | -$46.9M |
|
95
PUT
State Street SPDR S&P Biotech ETF
XBI
$9.95B
| – | – |
-1,127,200
| Closed | -$95.7M |
|
|
LCI
96
PUT
DELISTED
Lannett Company, Inc.
LCI
| – | – |
-130,200
| Closed | -$12.1M |
|
|
ZEN
97
DELISTED
ZENDESK INC
ZEN
| – | – |
-1,336,763
| Closed | -$45.2M |
|
|
HRC
98
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| – | – |
-477,370
| Closed | -$40.2M |
|
|
MNK
99
PUT
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| – | – |
-1,638,100
| Closed | -$37M |
|
|
AKRX
100
PUT
DELISTED
Akorn Inc
AKRX
| – | – |
-104,000
| Closed | -$3.35M |
|
Similar funds
DAM
MAM
LCM
DAM
KCM
CF
MIA
YL
PFM Health Sciences's Q1 2018 Portfolio in Review
As of Q1 2018, PFM Health Sciences held 109 positions worth $4.92B, up 17% from $4.22B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
PFM Health Sciences deployed $556M of net new capital in Q1 2018, opening 27 new positions and adding to 28 existing holdings. Its largest new stake was Bristol-Myers Squibb: 3,123,145 shares worth $198M.
By sector, the portfolio is most concentrated in Healthcare at 60% of assets, up from 48% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was ServiceNow, an estimated $80.6M trimmed.
- PFM Health Sciences's largest Q1 2018 buy was Bristol-Myers Squibb: 3,123,145 shares worth $198M.
- PFM Health Sciences added most to Elevance Health in Q1 2018, an estimated $92.3M increase.
- PFM Health Sciences's biggest Q1 2018 reduction was ServiceNow, cutting an estimated $80.6M.
- PFM Health Sciences fully exited Juno Therapeutics, Inc. in Q1 2018, selling an estimated $84.6M.
- PFM Health Sciences's ten largest holdings make up 31% of its $4.92B portfolio in Q1 2018.
- PFM Health Sciences opened 27 new positions and closed 16 in Q1 2018.
- PFM Health Sciences's portfolio value rose 17% quarter-over-quarter to $4.92B.
Based on PFM Health Sciences's 13F filing for Q1 2018, filed 15 May 2018.